Trent Reutiman
CEO and Director

Mr. Reutiman has 25 years of commercial experience in the medical device field, including leadership positions in sales and marketing, and sales management. He has significant expertise in commercializing products for minimally invasive interventional procedures, and participated in the development of many new technologies. Reutiman worked at Webster, TX-based IDEV Technologies from April 2012 to March 2014. Prior to that, from November 2006 to January 2012, he was Vice President of Sales and Marketing at San Clemente, CA-based ROX Medical, Inc. From March 2000 to December 2005 he was Vice President of Sales and Marketing at Mountain View, CA-based RITA Medical Systems. Before that Reutiman held sales management and representation positions at Guidant Corporation and Cordis Corporation. Reutiman has a bachelor of science degree in business from Colorado State University and an MBA from UC Irvine’s Paul Merage School of Business.

Kirk P. Seward, Ph.D.
Co-Founder, President, Chief Science and Technology Officer

Dr. Seward has over 20 years of experience in the medical device field. He is the inventor of the Mercator Micro-Infusion Catheter and led its development from prototype through FDA 510(k) marketing clearance and clinical development. Prior to co-founding Mercator MedSystems Dr. Seward was a staff principal investigator at Lawrence Livermore National Laboratory. He completed his doctoral studies in mechanical engineering at the University of California at Berkeley, and his masters and bachelors in mechanical engineering at MIT. He has authored more than 50 patent applications.

Steve Baker
Chief Financial Officer

Mr. Baker has over 25 years of experience as CFO of public and private companies in the medical device, biotech, software, SaaS, telecom and hardware industries. Since 2014 he has been CFO at Mercator MedSystems. He has significant expertise in building and leading organizations through rapid growth, fundraising and optimizing financial performance. Baker has held CFO and senior financial positions with FrontRange Solutions, PeopleSoft, Novell, Roamware, Geoworks, Octel Communications and AT&T. Baker has a bachelor of arts degree in molecular biology from University of Pennsylvania and an MBA from Columbia University Graduate School of Business.


Brad Cannon
Brad Cannon is the President of Sports Medicine and ENT at Smith+Nephew. He joined Smith+Nephew in 2012. Brad was most recently the Chief Marketing Officer and prior to that the President of Europe and Canada, where he successfully led the commercial business in those regions. He has also served as the President of Global Orthopaedic Franchises, leading Smith+Nephew’s Reconstruction, Endoscopy, Trauma and Extremities businesses. Prior to Smith+Nephew, Brad worked in Medtronic’s Spine and Biologics division. From 2009, he was responsible for Medtronic’s Spine International division and held positions heading US sales and global commercial operations. Brad is a graduate of Washington and Lee University, and the Wharton School of Business at the University of Pennsylvania.

Charles Crocker
Charles Crocker is a principal of Crocker Capital, a private venture capital firm active in life sciences. He recently served as Chairman of the Board and CEO of BEI Technologies, Inc., a public, diversified technology company that he founded and was recently sold to Schneider Electric. He was Chairman, CEO, and founder of BEI Medical Systems, a public medical device company that was sold to Boston Scientific. He serves on the boards of Franklin Resources, Inc. and its subsidiaries (parent of the Franklin Templeton Funds) and Teledyne Technologies, Inc. He is Chair of the Franklin Compensation Committee. Mr. Crocker has been Chairman of the Board of Children’s Hospital in San Francisco, Chairman of the Hamlin School’s Board of Trustees, President of the Foundation of the Fine Arts Museums of San Francisco, and a Trustee of the Buck Center for Research in Aging.  He currently serves as a Trustee of the Mary A. Crocker Trust. Mr. Crocker received his B.S. degree from Stanford University and an M.B.A from the University of California, Berkeley.

Ned Scheetz
Ned Scheetz is Managing Director and founder of Aphelion Capital, a Healthcare Venture Fund with an investment emphasis in medical technology, consumer health & wellness, diagnostics and research tools. He has been an investor in numerous public and private medical technology companies for nearly two decades. Mr. Scheetz was a partner and managing director with Piper Jaffray Ventures and a Senior Analyst with Janus Capital. Board positions have included InSound Medical, OrthAlign, OrthoScan, SurgiQuest, Suros Surgical, and VasoNova while active investments have included Broncus/Asthmatx, Fox Hollow, Insulet, SurgiCount Medical, and Tria Beauty. Prior to beginning his investment career Mr. Scheetz worked in various product management and sales roles with a subsidiary of Eastman Kodak and Kraft General Foods. Mr. Scheetz is an advisory board member with the Center for Medical Device Innovation, and on the business advisory board of The Epilepsy Therapy Development Project. Mr. Scheetz is a graduate of Colby College, Duke University’s Fuqua School of Business, and was a post-graduate scholar at Oxford University. Mr. Scheetz holds the CFA designation.

Doug Wall
Doug is the Managing Partner of Volcano Capital, LLC in New York. He is also a general partner of Summit Lifescience LP, a seed stage medical device fund located in Park City, Utah. Prior to Volcano Capital, he worked as an analyst at Outer Islands Capital, a hedge fund specializing in healthcare investments and led investor relations at Vital Signs, Inc. He is a board member of r4 Vascular Inc., Visionsense Ltd, Metascape and HydroCision.